Overexpressed‐eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma
Yi‐Wei Wang, Kuen‐Tyng Lin, Shu‐Chuan Chen, De‐Leung Gu, Chian‐Feng Chen, Pang‐Hsien Tu, Yuh‐Shan Jou – 4 March 2013 – Eukaryotic translation initiation factor 3 subunit I (eIF3I) with transforming capability is often overexpressed in human hepatocellular carcinoma (HCC) but its oncogenic mechanisms remain unknown. We demonstrate that eIF3I is overexpressed in various cancers along with activated Akt1 phosphorylation and kinase activity in an eIF3I dose‐dependent manner.